New Pandemic Agreement: Pharma Wins, Developing World Loses: AHF Institute
As the final Intergovernmental Negotiating Body (INB) meeting of the World Health Organization (WHO) Pandemic Agreement approaches, the AIDS Healthcare Foundation and the AHF Global Public Health Institute are voicing significant concerns about the April 16, 2024, Proposal for the WHO Pandemic Agreement.
Yes, we can end TB and AIDS.
Despite the achievements of the response to tuberculosis around the world, TB, a 100% curable disease, continues to claim thousands of lives.
International Women’s Day 2024 Empowered Women = Healthy Women
On International Women’s Day 2024, AHF joins the voice of millions of women in Latin America and the Caribbean on the road to achieve safety, equality and full respect for their rights.
February 13, International Condom Day 2024
2023 left us with a worrying increase in Sexually Transmitted Infections (STIs) in Latin America and The Caribbean, with rates remaining between 15% and 40% in syphilis, HIV, gonorrhea, and more.
Girls Act, in their own words
2022 marks the first five years of the Girls Act, a program which aims to provide tools for girls’ agency to use in difficult contexts and thus avoid acquiring HIV, unwanted pregnancies, violence or leaving school. Ultimately, these girls take ownership of their future and improve their communities.
Treatment and prevention are the keys to ending HIV
The world has the formula to end AIDS by 2030, but that goal will not be achieved without the necessary determination and action, says the Joint United Nations Program on HIV/AIDS (UNAIDS) in its most recent biannual report. The document explains that the path to end AIDS as a global health threat is clear and […]
Colombia challenges the patent of a drug against HIV
The Colombian government is about to authorize the entry of the generic version of dolutegravir, one of the most used and effective drugs in antiretroviral treatment, which controls HIV. Resolution 881 of 2023 was promoted by the Ministry of Health on June 2 and would allow Colombia to import or manufacture dolutegravir without requesting the […]
WHO recommends expanding access to HIV testing
The World Health Organization (WHO) has released new guidelines on HIV, highlighting the importance of expanding access to testing to get people living with the virus to undetectable levels. At the 12th International AIDS Society (IAS) Conference on HIV Science, which began on July 23 and ran for four days, WHO presented guidelines outlining HIV […]
People who “control” HIV, more susceptible to diseases
People ‘HIV controllers’ may be more susceptible to non-AIDS-related illnesses compared to people who are being treated for the infection, a new study has revealed. People living with the virus who do not need antiretroviral treatment are called “HIV controllers” – their bodies alone keep the amount of virus in their blood (viral load) low. […]
Successful trial of simplified treatment for HIV
A research team evaluated the effectiveness of using a single drug, rather than a combination of three or more, to treat HIV in people with early infection. Thus, the drug dolutegravir proved to be an effective long-term maintenance regimen in people who had started treatment soon after acquiring HIV, according to a small study published […]